Lexaria Bioscience Corp. (NASDAQ:LEXXW) Sees Large Drop in Short Interest

Lexaria Bioscience Corp. (NASDAQ:LEXXW) saw a significant decrease in short interest in the month of January. As of January 15th, there was short interest totalling 6,400 shares, a decrease of 21.0% from the December 31st total of 8,100 shares. Based on an average daily trading volume, of 5,500 shares, the days-to-cover ratio is presently 1.2 days.

Lexaria Bioscience Stock Down 13.7 %

Shares of NASDAQ LEXXW traded down $0.06 on Friday, hitting $0.38. The company’s stock had a trading volume of 3,172 shares, compared to its average volume of 8,534. Lexaria Bioscience has a 12-month low of $0.38 and a 12-month high of $2.50. The stock has a 50 day moving average of $0.68 and a 200-day moving average of $0.89.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.